Featured Article
A machine-learning algorithm can sift through electronic health records to identify patients with a rare immune condition long before their official diagnosis, research shows, potentially speeding referral to specialist treatment.
Precision Oncology Today
Magazine
Beginning a New Era of Precision Alzheimer’s Therapeutics
Alzheimer’s is a disease associated with aging and impacts almost seven million people in the U.S. over the age of 65, with women and Black or Hispanic populations disproportionately affected by the condition. Finding an effective treatment for Alzheimer’s disease has proved to be a long and difficult quest.
5 Startups With Proteomics Potential Attracting Investor Cash
Investor appetite is growing for startups that can make proteomics faster, cheaper, and more informative for use in precision medicine. Here are five proteomics...
Trending on Inside Precision Medicine
Researchers Discover Biomarkers Indicative of Stroke Risk
Inflammatory molecules in the IL-18 network can be used to calculate the risk for cerebral small vessel disease, a common cause of stroke.
AI Identifies Rare Diseases in Health Records
A machine-learning algorithm can sift through electronic health records to identify patients with a rare immune condition long before their official diagnosis, research shows, potentially speeding referral to specialist treatment.
New Signaling Pathway and Potential Drug Found for MASH
Researchers have uncovered a pathway that leads to fatty liver, or MASH, and designed a drug candidate to affect this pathway.
